In the urgent space between consciousness and the breathing tube, clinicians have long sought certainty where medicine offers only trade-offs. A large American multicenter trial enrolling 2,365 critically ill adults compared ketamine and etomidate for rapid sequence intubation, hoping to resolve a debate that has shaped emergency and intensive care practice for years. The study found equivalent 28-day mortality between the two drugs, yet revealed that ketamine carries a meaningfully higher risk of immediate cardiovascular collapse — particularly in the sickest patients. The question of which d
Ketamine vs. Etomidate for Rapid Sequence Intubation: No Clear Winner
Cobertura Relacionada
Simone Mendes apresentou show na madrugada de quinta-feira (27) no Palco Estádio da Festa do Peão de Barretos, animando …
G1 · Aug 27 Influenciadora esfaqueia suspeito de abusar da filha em Franca; caso é investigadoInfluenciadora de 25 anos feriu com canivete homem acusado de abusar sexualmente da filha de 5 anos em Franca, SP. Políc…
G1 · Aug 27 Vereador preso por crimes sexuais recorre ao STF para recuperar salário de R$ 18,5 milVereador de Piracicaba preso desde dezembro de 2025 e acusado de crimes sexuais contra 12 mulheres recorre ao STF para r…
G1 · Aug 27 Cirurgião de empresária morta na BA enfrentou denúncias de pacientes em 2023Cirurgião plástico responsável pela morte de empresária em Ilhéus havia sido denunciado por pacientes em 2023 por compli…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
Medical study on anesthetic agents for intubation has no geopolitical implications; this is a clinical research article, not a geopolitical matter.
Lente Econômica
Randomized trial of 2,365 critically ill patients shows ketamine and etomidate have similar 28-day mortality for rapid intubation, but ketamine increases cardiovascular collapse risk, with no clear clinical winner.
Patients requiring emergency intubation will continue to have drug selection based on individual clinical factors rather than mortality advantage. Healthcare costs may remain stable as both drugs are likely similarly priced, but hospitals may adjust protocols based on cardiovascular stability concerns.
Medical societies may need to update clinical guidelines to emphasize individualized drug selection rather than universal recommendations. Hospitals may implement risk-stratification protocols to guide ketamine vs. etomidate use based on patient sepsis status and APACHE scores. Potential for increased monitoring requirements if ketamine use continues.